David Jacobsohn, MD, Pediatric Hematology & Oncology, Washington, DC, Children's National Hospital


Pediatric Hematology & Oncology Washington, DC

Professor, Pediatrics, George Washington University School of Medicine and Health Sciences

Dr. Jacobsohn is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jacobsohn's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1999 - 2002
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1996 - 1999
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 1996

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2020 - 2022
  • DC State Medical License
    DC State Medical License 2010 - 2020
  • IL State Medical License
    IL State Medical License 2002 - 2011
  • MD State Medical License
    MD State Medical License 2000 - 2002
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Top Doctors:Washington DC Area Castle Connolly, 2012

Clinical Trials

Publications & Presentations


Journal Articles

  • Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors  
    Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
  • Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in Neuroblastoma  
    Gregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature


  • Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)
    David Jacobsohn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019


  • Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)Cl... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Liaison's Fully AGNIS-Compatible BMT Registry to Debut at BMT Tandem Meetings
    Liaison's Fully AGNIS-Compatible BMT Registry to Debut at BMT Tandem MeetingsJanuary 26th, 2016

Hospital Affiliations